Skip to content

Prospective study of treatment of children with attention deficit/hyperactivity disorder based on digital therapy software

Prospective study of treatment of children with attention deficit/hyperactivity disorder based on digital therapy software

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070521
Enrollment
Unknown
Registered
2023-04-14
Start date
2022-03-10
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

attention deficit/hyperactivity disorder

Interventions

intervention group:ADHD children trained with Brainfit received a total of 12 times, 30-minute interventions every time.
control group:Typical development children trained with Brainfit received a total of 12 times, 30-minute interventions every time.
watilist group:no intervention will be accepted

Sponsors

Children's Hospital Affiliated to Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Criteria for ADHD group :(1) meeting the diagnostic criteria of dsm-5 for attention deficit hyperactivity disorder; (2) 6-12 years old; (3) IQ =80; (4) The guardian agrees and signs the informed consent. Inclusion criteria for health controls :(1) 6-12 years old; (2) IQ =80; (3) The guardian agrees and signs the informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria for ADHD group :(1) patients with other serious mental diseases and diseases that may lead to attention deficit, such as abnormal blood glucose, anemia, hyperthyroidism, hyperadrenal cortex, etc.; (2) Children who are currently taking ADHD drugs (such as methylphenidate and tomoxetine) or have taken them in the past 1 month; (3) Those who have a history of nervous system diseases and serious physical diseases are not suitable to participate in game training. Exclusion criteria for health control group :(1) a clear history of craniocerebral trauma; (2) suffering from other serious mental diseases and diseases that may lead to attention deficit, such as abnormal blood glucose, anemia, hyperthyroidism, hyperadrenal cortex, etc.; (3) Pervasive developmental disorder, attention deficit hyperactivity disorder, behavioral disorder and other mental disorders.

Design outcomes

Primary

MeasureTime frame
Behavior Rating Inventory of Executive Function;Swanson, Nolan and Pelham-IV rating scales;

Secondary

MeasureTime frame
Conners Parent Symptom Questionnaire;

Countries

CHINA

Contacts

Public ContactFang Shuanfeng

Children's Hospital Affiliated to Zhengzhou University

fangshuanfeng@126.com+86 13937193903

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026